{
  "id": "mhgap#risk_safety_16c668ed",
  "content": "Deterioration of social functioning (i.e. difficulties at work\nreport any problems with substance use. Look for:\nor home, unkempt appearance)\n– Recurrent requests for psychoactive medications including\nSigns of chronic liver disease (abnormal liver enzymes),\nanalgesics\njaundiced (yellow) skin and eyes, palpable and tender liver\nedge (in early liver disease), ascites (distended abdomen is filled – Injuries\nwith fluid), spider naevi (spider-like blood vessels visible on\n– Infections associated with intravenous drug use (HIV/AIDS,\nthe surface of the skin), and altered mental status (hepatic\nHepatitis C)\nencephalopathy)\nProblems with balance, walking, coordinated movements,\nand nystagmus\nCLINICAL TIP\n»\nAvoid stereotyping! All persons presenting to\nhealth care facilities should be asked about\ntheir tobacco and alcohol use.\nBOX 1: PSYCHOACTIVE SUBSTANCES: ACUTE BEHAVIOURAL EFFECTS, WITHDRAWAL FEATURES, AND EFFECTS OF PROLONGED USE\nACUTE BEHAVIOURAL EFFECTS WITHDRAWAL FEATURES EFFECTS OF PROLONGED USE\nAlcohol Smell of alcohol on breath, slurred speech, disinhibited Tremors, shaking, nausea/vomiting, increased heart rate Loss of brain volume, reduction in cognitive capacity,\nbehavior, agitation, vomiting, unsteady gait and blood pressure, seizures, agitation, confusion, impaired judgement, loss of balance, liver fibrosis,\nhallucinations gastritis, anaemia, increased risk of some cancers and a\nCan be life-threatening range of other medical problems",
  "metadata": {
    "source": "WHO mhGAP-IG 2023",
    "url": "https://www.who.int/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "work",
      "emotions",
      "coping_skill",
      "risk_safety",
      "management"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General — Risk Safety Deterioration of social functioning (i.e. difficulties at work\nreport any problems with substance use. Look for:\nor home, unkempt appearance)\n– Recurrent requests for psychoactive medications including\nSigns of chronic liver disease (abnormal liver enzymes),\nanalgesics\njaundiced (yellow) skin and eyes, palpable and tender liver\nedge (in early liver disease), ascites (distended abdomen is filled – Injuries\nwith fluid), spider naevi (spider-like blood vessels visible on\n– Infections associated with intravenous drug use (HIV/AIDS,\nthe surface of the skin), and altered mental status (hepatic\nHepatitis C)\nencephalopathy)\nProblems with balance, walking, coordinated movements,\nand nystagmus\nCLINICAL TIP\n»\nAvoid stereotyping! All persons presenting to\nhealth care facilities should be asked about\ntheir tobacco and alcohol use.\nBOX 1: PSYCHOACTIVE SUBSTANCES: ACUTE BEHAVIOURAL EFFECTS, WITHDRAWAL FEATURES, AND EFFECTS OF PROLONGED USE\nACUTE BEHAVIOURAL EFFECTS WITHDRAWAL FEATURES EFFECTS OF PROLONGED USE\nAlcohol Smell of alcohol on breath, slurred speech, disinhibited Tremors, shaking, nausea/vomiting, increased heart rate Loss of brain volume, reduction in cognitive capacity,\nbehavior, agitation, vomiting, unsteady gait and blood pressure, seizures, agitation, confusion, impaired judgement, loss of balance, liver fibrosis,\nhallucinations gastritis, anaemia, increased risk of some cancers and a\nCan be life-threatening range of other medical problems Deterioration of social functioning (i.e. difficulties at công việc\nreport any problems with substance use."
}